Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF96.7.
  • 活动
  • 新闻
  • 行业洞察
  • 账户
Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

News

Categories

  • 最新
  • 中国与金砖国家+
  • 人工智能与科技
  • 供应链
  • 农业
  • 创业与风险投资
  • 医疗健康
  • 半导体
  • 国防
  • 机器人
  • 网络安全
  • 能源与出行
  • 金融科技

Select a category to explore the latest industry reporting.

NewsTuesday, 25 August 2026
Newsletter subscribe · Free
  • 最新
  • 人工智能与科技
  • 网络安全
  • 半导体
  • 机器人
  • 金融科技
  • 能源与出行
  • 国防
  • 医疗健康
  • 供应链
  • 创业与风险投资
  • 中国与金砖国家+
  • 农业

新闻

医疗健康

来自塑造行业的会议、展会和峰会的 医疗健康 领域最新新闻、公告和分析。

该分类的最新新闻

STAT+: Kennedy heads west, slams Becerra (opens original source in a new tab)
STAT News

STAT+: Kennedy heads west, slams Becerra

The health secretary headed to California to lay out the government's new approach to addiction treatment.

Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

(opens original source in a new tab)
John Wilkerson·13 August 2026
STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more (opens original source in a new tab)
STAT News

STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

Seven months after the launch of its own low-cost insulin brand, California has distributed more than 120,000 five-pen packs of insulin glargine priced at $55 each

(opens original source in a new tab)
Ed Silverman·13 August 2026
STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices (opens original source in a new tab)
STAT News

STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices

In this edition of STAT Health Tech: a deep dive into General Catalyst-backed Commure, and Medicare's tech incentives for AI devices.

(opens original source in a new tab)
Katie Palmer·13 August 2026
STAT+: Neurocrine Biosciences and the delicate balance of benefit and risk (opens original source in a new tab)
STAT News

STAT+: Neurocrine Biosciences and the delicate balance of benefit and risk

When it comes to rare disease treatments, patients often confront a difficult risk-benefit calculus. Such is the case with a therapy from Neurocrine Biosciences.

(opens original source in a new tab)
Adam Feuerstein·13 August 2026
STAT+: What patients actually think about ‘minimally invasive’ brain implants (opens original source in a new tab)
STAT News

STAT+: What patients actually think about ‘minimally invasive’ brain implants

A new study polled people with treatment-resistant depression about what matters to them when it comes to brain implants for mental health.

(opens original source in a new tab)
O. Rose Broderick·13 August 2026
Opinion: I’ve seen what life is like without vaccines. Americans need to understand what they save us from (opens original source in a new tab)
STAT News

Opinion: I’ve seen what life is like without vaccines. Americans need to understand what they save us from

“The ability to prevent a deadly infectious disease is an extraordinary privilege,” writes infectious disease physician Krutika Kuppalli.

(opens original source in a new tab)
Krutika Kuppalli·13 August 2026
STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals (opens original source in a new tab)
STAT News

STAT+: What Medicare incentives for AI-based devices mean for tech companies — and hospitals

As Medicare pays hospitals when they use newly-authorized AI devices, researchers say those payments could incentivize overuse.

(opens original source in a new tab)
Katie Palmer·13 August 2026
Opinion: How to disrupt the health misinformation business model (opens original source in a new tab)
STAT News

Opinion: How to disrupt the health misinformation business model

One way to fight medical misinformation: make it easier for people to understand when they are being manipulated, write Paul Martin Jensen and Avi Tuschman.

(opens original source in a new tab)
Paul Martin Jensen and Avi Tuschman·13 August 2026
Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says (opens original source in a new tab)
STAT News

Talks on launch of clinical trial of Ebola vaccine in DRC advance, WHO says

Talks are underway between the Democratic Republic of the Congo and the WHO to expedite the start of a multi-armed Phase 3 clinical trial of Ebola vaccines.

(opens original source in a new tab)
Helen Branswell·12 August 2026
Vaping and cannabis hit record highs among young adults in 2025: Survey (opens original source in a new tab)
STAT News

Vaping and cannabis hit record highs among young adults in 2025: Survey

Young adults’ use of vapes and cannabis hit all-time highs last year, according to a new survey.

(opens original source in a new tab)
Sarah Todd·12 August 2026
STAT+: Providers notch No Surprises Act legal win that could boost their pay (opens original source in a new tab)
STAT News

STAT+: Providers notch No Surprises Act legal win that could boost their pay

The change could boost how much health insurers, and patients, pay for some care.

(opens original source in a new tab)
Tara Bannow·12 August 2026
Trump administration’s new ‘treatment first’ addiction toolkit emphasizes faith, abstinence (opens original source in a new tab)
STAT News

Trump administration’s new ‘treatment first’ addiction toolkit emphasizes faith, abstinence

The White House nods to use of addiction medications but moves away from other harm reduction strategies.

(opens original source in a new tab)
Lev Facher·12 August 2026

最多阅读

  1. 01

    STAT+: Kennedy heads west, slams Becerra

  2. 02

    STAT+: Pharmalittle: We’re reading about California insulin sales, a Moderna patent battle, and more

  3. 03

    STAT+: An investigation into Commure, and Medicare’s new-tech incentives for AI devices

  4. 04

    STAT+: Neurocrine Biosciences and the delicate balance of benefit and risk

  5. 05

    STAT+: What patients actually think about ‘minimally invasive’ brain implants

Prev
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
Next
  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF96.7.

每周五送达的行业活动一周要闻。

一封简短的邮件。汇集塑造全球商业的展会、会议和峰会的头条新闻。没有废话,没有垃圾邮件,随时可取消订阅。